Codexis is in the process of developing an enzyme substitution therapy for patients with Homocystinuria due to CBS deficiency (Classical HCU). Learn more about their therapy pipeline here
Codexis is in the process of developing an enzyme substitution therapy for patients with Homocystinuria due to CBS deficiency (Classical HCU). Learn more about their therapy pipeline here
© 2016 Enigma Theme|Theme Developed By Weblizar Themes